Location History:
- Yokohama, JP (2015)
- Tokyo, JP (2016)
Company Filing History:
2 out of 1,235 
2 out of 6 Years Active: 2015-2016
Title: Makiko Yui: Innovator in Hematopoietic Stem Cell Research
Introduction
Makiko Yui is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of hematopoietic stem cell research, holding two patents that focus on innovative methods for expanding these vital cells. Her work is crucial for advancing gene therapy techniques aimed at treating various hematopoietic disorders.
Latest Patents
Yui's latest patents include a method for expanding hematopoietic stem cells using heterocyclic compounds. This patent provides an expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells, which enhances the efficiency of gene transfer into these cells for gene therapy applications. The method involves culturing hematopoietic stem cells ex vivo in the presence of a specific compound, which is detailed in the patent description.
Another significant patent by Yui focuses on producing hematopoietic stem cells using pyrazole compounds. This method also serves as an expanding agent for hematopoietic stem cells and/or progenitor cells, improving gene transfer efficiency for therapeutic purposes. The process includes expanding hematopoietic stem cells by culturing them ex vivo with a defined compound, as outlined in the patent.
Career Highlights
Throughout her career, Makiko Yui has worked with notable companies such as Nissan Chemical Industries Limited and Reprocell, Inc. Her experience in these organizations has contributed to her expertise in stem cell research and development.
Collaborations
Yui has collaborated with esteemed colleagues, including Taito Nishino and Yasuyuki Asai. These partnerships have furthered her research and innovation in the field of hematopoietic stem cells.
Conclusion
Makiko Yui is a trailblazer in hematopoietic stem cell research, with her patents paving the way for advancements in gene therapy. Her contributions are vital for the treatment of hematopoietic disorders, showcasing her dedication to innovation in the medical field.